| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |